...
首页> 外文期刊>Molecular medicine today >Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate.
【24h】

Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate.

机译:自我更新,分化或死亡:造血干细胞命运的调控和操纵。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hematopoietic stem cells (HSCs) are the rare cells from which all hematopoietic cells are derived. The absence of HSCs is not compatible with life because many essential cells, such as myeloid and erythroid cells, are short lived. The hematopoietic system is the first essential organ system that fails following cytotoxic treatments. It is the vulnerability of HSCs that prevents regeneration following treatment and thus long-term survival. Because HSCs have the capacity to regenerate a functional hematopoietic system, the manipulation of these cells in vitro holds many promises for gene-therapeutic and other applications; however, these are severely curtailed by current difficulties in maintaining and expanding HSCs in culture. This review focuses on recent approaches towards understanding how the HSC compartment is regulated in vivo and discusses how this knowledge might be applied to manipulating HSC numbers.
机译:造血干细胞(HSC)是所有造血细胞所衍生的稀有细胞。 HSC的缺乏与生命不相容,因为许多必需细胞(如髓样细胞和红系细胞)的寿命很短。造血系统是在细胞毒性治疗后失效的第一个重要器官系统。造血干细胞的脆弱性阻止了治疗后的再生,从而阻止了其长期生存。由于HSC具有再生功能性造血系统的能力,因此在体外对这些细胞的操纵为基因治疗和其他应用带来了许多希望。然而,由于目前在维持和扩大文化中的HSC方面的困难,这些问题被严重限制。这篇综述集中在了解HSC舱室如何在体内进行调节的最新方法,并讨论了如何将这种知识应用于操纵HSC编号。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号